Prosecution Insights
Last updated: April 19, 2026
Application No. 18/156,947

IMPROVED CATALYSTS FOR INTERMOLECULAR CYCLOADDITION

Non-Final OA §103
Filed
Jan 19, 2023
Examiner
QIAN, YUN
Art Unit
1738
Tech Center
1700 — Chemical & Materials Engineering
Assignee
The Trustees of Princeton University
OA Round
1 (Non-Final)
54%
Grant Probability
Moderate
1-2
OA Rounds
3y 3m
To Grant
75%
With Interview

Examiner Intelligence

Grants 54% of resolved cases
54%
Career Allow Rate
588 granted / 1081 resolved
-10.6% vs TC avg
Strong +20% interview lift
Without
With
+20.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
60 currently pending
Career history
1141
Total Applications
across all art units

Statute-Specific Performance

§101
0.1%
-39.9% vs TC avg
§103
44.3%
+4.3% vs TC avg
§102
16.8%
-23.2% vs TC avg
§112
26.8%
-13.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1081 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. Response to Election/Restrictions Applicant’s election with traverse of Group I claims 1-12 in the reply filed on 12/10/2025 is acknowledged. Applicant elected the species of [2,6-Bis(1-(2,6-dimethylphenylimino)pentyl)pyridine] iron butadiene (Catalyst 3), and further elects catalyst species [2,6-Bis(1-(2,6- dimethylphenylimino)pentyl)pyridine] iron methyl (Catalyst 4) recited in claim 10 having the structures as shown below (the instant Specification page 26): PNG media_image1.png 174 390 media_image1.png Greyscale As we see above, the Catalyst 3 falls within the scope of formula (I), however the Catalyst 4 fails within the scope of formula (II). Per conversation with applicant’s representative Mr. Robb D. Edmonds on 12/22/2025, applicant elected the species of the Catalyst 3 without traverse. Therefore, the E1-3 recited in formula (I) as being carbon. Regarding Group election, the traversal is on the ground(s) that no search burden exists. Applicants’ arguments are not found persuasive as indicated in the previous office action mailed on 08/27/2025, there would be a serious search and examination burden if restriction were not required because one or more of the following reasons apply: (a) the inventions have acquired a separate status in the art due to their recognized divergent subject matter; (b) the inventions require a different field of search (for example, searching different classes/subclasses or electronic resources, or employing different search queries); (c) the prior art applicable to one invention would not likely be applicable to another invention; (d) the inventions are likely to raise different non-prior art issues under 35 U.S.C. 101 and/or 35 U.S.C. 112, first paragraph; (e) different search queries are required to account for the differing active steps of the method groups, which are not present in the composition claims, thus causing a serious and examination burden. In this case, the different fields of searches are required for the method of making of nanoparticles and using the nanoparticles (i.e. specific steps involved in these processes, etc.). Therefore there would be a serious search and examination burden if restriction were not required. Claims 13-24 are withdrawn from consideration as non-elected Group. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 1-9 and 11-12 are rejected under 35 U.S.C. 103 as being unpatentable over Delis et al. (WO 2011/006044 A2). Regarding claim 1, Delis et al. teach iron catalyst containing terdentate pyridine diimine ligand formula (II) having the structure as shown below (pages 3-4): PNG media_image2.png 560 826 media_image2.png Greyscale PNG media_image3.png 538 868 media_image3.png Greyscale As we see above, the iron catalyst of the Formula (II) taught by Delis et al. corresponds to the instant claimed catalyst compound represented by Formula (I) wherein alternative selected as G=Fe, R3=C1-18 alkyl, R4-9, 11-12=H, R23=2-6-dimethylphenyl ([0042]), R1-2=Methyl, L-L2=diene. Regarding claims 2-3, as discussed above, the pyridine ring in the iron catalyst of the Formula (II) taught by Delis et al. corresponds to the instant Formula (I) wherein E1-3=C, R3-5=H. Regarding claims 4-5, as discussed above, the Formula (A) in the iron catalyst of the Formula (II) taught by Delis et al. is 1, 3-pentadiene R10-13 and 14-16=H, R12=CH2 which corresponds to the X1 and X2 in instant Formula (I). Regarding claim 6, as discussed above, the R23 and R1-2, 4-6 in the Formula (II) taught by Delis et al. are 2,6-dimethylphenyl groups as the instant claim (R1-2=methyl, R4-6=H, [0042]): PNG media_image4.png 386 924 media_image4.png Greyscale Regarding claims 7-9, as discussed above, the R3 groups in the iron catalyst of the Formula (II) taught by Delis et al. are C1-18 alkyl groups. The prior art compounds are true homologs of the claimed compounds, the similarity between the chemical structures and properties is sufficiently close that one on ordinary skill in the arts would have been motivated to make the claimed compounds in searching for iron catalysts. Therefore, the invention as a whole would have been prima facie obvious to one of ordinary skill in the art at the time the invention was made See MPEP 2144.09 I-III. Regarding claims 11-12, the L1-L2 in the iron catalyst of the Formula (II) taught by Delis et al. include butadiene (a conjugated diene) obtained after filtration on aa filter frit ([00118]). A product-by-process limitation of “wherein the catalyst is generated by addition of a conjugated diene…” of claim 11, and “wherein is purified by filtration…” of claim 12 is noted. It is considered while the product of the reference is made by a different process, the product made and disclosed is the same as being claimed. see "[E]ven though product-by-process claims are limited by and defined by the process, determination of patentability is based on the product itself. The patentability of a product does not depend on its method of production. If the product in the product-by-process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process." (In re Thorpe, 227 USPQ 964,966). Once the Examiner provides a rationale tending to show that the claimed product appears to be the same or similar to that of the prior art, although produced by a different process, the burden shifts to applicant to come forward with evidence establishing an unobvious different between the claimed product and the prior art product (In re Marosi, 710 F.2d 798, 802,218 USPQ 289, 292 (Fed. Cir. 1983). See MPEP 2113. Allowable Subject Matter Claim 10 including only the elected species would be allowable if rewritten to overcome the rejections as discussed above. The Examiner searched the elected species as discussed above. There was no prior art discovered on the particular elected species. Therefore, the search of the species has been extended to the non-elected the compound represented by the Formula (I) as discussed above. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to YUN QIAN whose telephone number is (571)270-5834. The examiner can normally be reached Monday-Thursday 10:00am-4:00pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sally A Merkling can be reached on 571-272-6297. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. YUN . QIAN Examiner Art Unit 1732 /YUN QIAN/ Primary Examiner, Art Unit 1738
Read full office action

Prosecution Timeline

Jan 19, 2023
Application Filed
Dec 10, 2025
Response Filed
Dec 23, 2025
Non-Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12600906
RED-LUMINESCENT PHOSPHOR WITH LONG AFTERGLOW AND FABRICATION METHOD THEREOF
2y 5m to grant Granted Apr 14, 2026
Patent 12595171
Co-production of Hydrogen and Sulfuric Acid by Partial Oxidation of Sulfur
2y 5m to grant Granted Apr 07, 2026
Patent 12592423
PROCESS AND ITS PRODUCTS FOR SPENT LITHIUM-ION BATTERIES TREATMENT
2y 5m to grant Granted Mar 31, 2026
Patent 12589383
Spherical Titanium Silicalite Molecular Sieve Catalyst and Preparation Method Therefor
2y 5m to grant Granted Mar 31, 2026
Patent 12577126
METHOD FOR PRODUCING NICKEL PARTICLES, METHOD FOR PRODUCING NICKEL SULFATE, AND METHOD FOR PRODUCING POSITIVE ELECTRODE ACTIVE MATERIAL FOR SECONDARY BATTERIES
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
54%
Grant Probability
75%
With Interview (+20.3%)
3y 3m
Median Time to Grant
Low
PTA Risk
Based on 1081 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month